Expression of human mucous proteinase inhibitor in respiratory tract: a study by in situ hybridization.
Author(s) -
Isabelle Van Seuningen,
J P Audie,
Bernard Gosselin,
J.J. Lafitte,
M Davril
Publication year - 1995
Publication title -
journal of histochemistry and cytochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 124
eISSN - 1551-5044
pISSN - 0022-1554
DOI - 10.1177/43.6.7769236
Subject(s) - in situ hybridization , serous fluid , pathology , respiratory tract , submucosal glands , immunohistochemistry , biology , immunogold labelling , gene expression , slpi , microbiology and biotechnology , respiratory system , gene , anatomy , medicine , inflammation , ultrastructure , immunology , biochemistry
Human mucous proteinase inhibitor (MPI) is present in bronchial secretions, where it participates in the protection of lung structures against degradation by leukocyte elastase. The protein has been localized by immunohistochemical studies and immunogold labeling essentially in the serous cells of the submucosal glands and also in the surface epithelial cells of central and peripheral airways. However, until now no gene expression study has been performed at the tissue level. In this study, in situ hybridization was used to precisely study MPI mRNA expression in bronchial tissue sections with a specific radiolabeled oligonucleotide probe. By light microscopy, MPI gene expression was localized exclusively in the serous and seromucinous acini of the submucosal glands of large airways. The MPI gene was expressed in submucosal glands of normal and carcinomatous tissue sections, whereas it was not expressed in bronchial and bronchiolar surface epithelia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom